Brief: Expres2ion Biotech Holding Q1 Loss Widens To SEK 14.8 Mln
May 31 (Reuters) - ExpreS2ion Biotech Holding AB
EXPRS2.ST :
* Q1 LOSS AFTER FINANCIAL ITEMS SEK 14.8 MILLION VERSUS LOSS
SEK
12.1 MILLION YEAR AGO
* Q1 LOSS FOR PERIOD -13,836 (-11,155) KSEK
* Q1 OPERATING INCOME 2,078 (1,931) KSEK
Source text for Eikon: ID:nWkr3CLQVh
Further company coverage: EXPRS2.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations